Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas - PubMed (original) (raw)
Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas
P Corradini et al. J Exp Med. 1993.
Abstract
Multiple myeloma is a B cell malignancy characterized by the expansion of plasma cells producing monoclonal immunoglobulins (Ig). It has been regarded as a tumor arising at the B, pre-B lymphocyte, or even stem cell level. Precursor cells are presumed to proliferate and differentiate giving rise to the plasma cell clonal expansion. Antigenic features and specific Ig gene rearrangement shared by B lymphocytes and myeloma cells have supported this hypothesis. However, the existence of such a precursor is based upon indirect evidence and is still an open question. During differentiation, B cells rearrange variable (V) regions of Ig heavy chain genes, providing a specific marker of clonality. Using an anchor polymerase chain reaction assay, these rearranged regions from five patients with multiple myeloma were cloned and sequenced. The switch of the Ig constant (C) region was used to define the B cell differentiation stage: V regions are linked to C mu genes in pre-B and B lymphocytes (pre-switch B cells), but to C gamma or C alpha in post-switch B lymphocytes and plasma cells (post-switch B cells). Analysis of bone marrow cells at diagnosis revealed the presence of pre-switch B cells bearing plasma cell V regions still joined to the C mu gene. These cells were not identified in peripheral blood, where tumor post-switch B cells were detected. These pre-switch B cells may be regarded as potential myeloma cell precursors.
Similar articles
- The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression.
Arpin C, de Bouteiller O, Razanajaona D, Fugier-Vivier I, Brière F, Banchereau J, Lebecque S, Liu YJ. Arpin C, et al. J Exp Med. 1998 Apr 20;187(8):1169-78. doi: 10.1084/jem.187.8.1169. J Exp Med. 1998. PMID: 9547329 Free PMC article. - The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
Billadeau D, Ahmann G, Greipp P, Van Ness B. Billadeau D, et al. J Exp Med. 1993 Sep 1;178(3):1023-31. doi: 10.1084/jem.178.3.1023. J Exp Med. 1993. PMID: 8350044 Free PMC article. - Multiple myeloma: new evidence and insights from the immunoglobulin heavy chain gene and phenotypes.
Takishita M, Kosaka M. Takishita M, et al. Leuk Lymphoma. 1995 Nov;19(5-6):395-400. doi: 10.3109/10428199509112196. Leuk Lymphoma. 1995. PMID: 8590838 Review. - Molecular analysis of immunoglobulin genes in multiple myeloma.
Kosmas C, Stamatopoulos K, Stavroyianni N, Belessi C, Viniou N, Yataganas X. Kosmas C, et al. Leuk Lymphoma. 1999 Apr;33(3-4):253-65. doi: 10.3109/10428199909058425. Leuk Lymphoma. 1999. PMID: 10221505 Review.
Cited by
- A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease Complexity.
Da Vià MC, Ziccheddu B, Maeda A, Bagnoli F, Perrone G, Bolli N. Da Vià MC, et al. Hemasphere. 2020 Nov 24;4(6):e502. doi: 10.1097/HS9.0000000000000502. eCollection 2020 Dec. Hemasphere. 2020. PMID: 33283171 Free PMC article. Review. - The myeloma stem cell concept, revisited: from phenomenology to operational terms.
Johnsen HE, Bøgsted M, Schmitz A, Bødker JS, El-Galaly TC, Johansen P, Valent P, Zojer N, Van Valckenborgh E, Vanderkerken K, van Duin M, Sonneveld P, Perez-Andres M, Orfao A, Dybkær K. Johnsen HE, et al. Haematologica. 2016 Dec;101(12):1451-1459. doi: 10.3324/haematol.2015.138826. Epub 2016 Nov 10. Haematologica. 2016. PMID: 27903712 Free PMC article. Review. - In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival.
Debes Marun CS, Belch AR, Pilarski LM. Debes Marun CS, et al. Am J Hematol. 2012 Jun;87(6):579-87. doi: 10.1002/ajh.23194. Epub 2012 Apr 12. Am J Hematol. 2012. PMID: 22495885 Free PMC article. - Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myeloma.
Trepel M, Martens V, Doll C, Rahlff J, Gösch B, Loges S, Binder M. Trepel M, et al. PLoS One. 2012;7(2):e31998. doi: 10.1371/journal.pone.0031998. Epub 2012 Feb 22. PLoS One. 2012. PMID: 22384124 Free PMC article. - Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma.
Rasmussen T, Haaber J, Dahl IM, Knudsen LM, Kerndrup GB, Lodahl M, Johnsen HE, Kuehl M. Rasmussen T, et al. Haematologica. 2010 Oct;95(10):1730-7. doi: 10.3324/haematol.2010.024778. Epub 2010 May 29. Haematologica. 2010. PMID: 20511669 Free PMC article.
References
- Cell. 1984 Apr;36(4):801-3 - PubMed
- Cell. 1984 Mar;36(3):681-8 - PubMed
- J Clin Invest. 1985 Sep;76(3):1243-51 - PubMed
- J Immunol. 1987 Jun 15;138(12):4150-8 - PubMed
- Blood. 1987 Nov;70(5):1550-3 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous